The IL-1β/TNF-α/NF-κB pathway is activated during the inflammation initiation process, and HRP can downregulate its activation in a dose-dependent manner, implying that this pathway is involved in the initiation of hepatitis. This evidence concerns the gene IL1B and hepatitis A virus infection.